MedTech Dive July 22, 2024
Susan Kelly

Stacey Churchwell, who leads cardiovascular diagnostics and services, says artificial intelligence is reducing false positives in Medtronic’s insertable cardiac monitors, saving clinicians time.

Medtech companies are rapidly integrating artificial intelligence into cardiovascular medicine, from imaging and electrocardiology to genetics and patient monitoring. Best practices are still evolving, however, and few AI tools have been shown to improve cardiovascular and stroke care enough to be widely adopted, according to a recent statement from the American Heart Association.

Medtronic is among the device makers working to support earlier disease detection and treatment through AI-enabled technologies. The company told MedTech Dive that better algorithms and sensing technologies and an expansion of available data are improving accuracy and access across multiple specialties. For example,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Interview / Q&A, Medical Devices, Patient / Consumer, Provider, Technology, Trends
Promise and Perils of AI in Medicine
Samsung Acquires AI-Powered Prenatal Ultrasound Startup
Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
Samsung finalizes $92M acquisition of French ultrasound AI firm Sonio
Medtech venture investment recovery continues, but startup M&A remains limited: Pitchbook

Share This Article